CALCNasdaqPharmaceutical PreparationsFiscal year ends December 31
CalciMedica, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$1.02−0.02 (-1.92%)
Close on Oct 19, 2026
- Market cap
- $17.44M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$15.03 (−93.64%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsSplit
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $17.44M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 3.16
- Dividend yield
- –
- Free cash flow yield
- -109.62%
Fundamentals
- Net income
- -$21.24M
- EPS, diluted
- -$1.35
- Free cash flow
- -$19.12M
- Book value per share
- $0.32
- Diluted shares
- 17M
Eight years at a glance
Fiscal years 2018 to 2025 and trailing twelve months, USD
Operating income
-$19.63M
Net income
-$21.24M
EPS, diluted
-$1.35
Free cash flow
-$19.12M
Reported periodTrailing twelve months